Femasys (FEMY) Revenue & Revenue Breakdown
Femasys Revenue Highlights
Latest Revenue (Y)
$1.63M
Latest Revenue (Q)
$729.39K
Femasys Revenue by Period
Femasys Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $1.63M | 51.97% |
| 2023-12-31 | $1.07M | -11.13% |
| 2022-12-31 | $1.21M | 2.25% |
| 2021-12-31 | $1.18M | 13.66% |
| 2020-12-31 | $1.04M | 11.72% |
| 2019-12-31 | $929.06K | - |
Femasys generated $1.63M in revenue during NA 2024, up 51.97% compared to the previous quarter, and up 175.35% compared to the same period a year ago.
Femasys Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-09-30 | $729.39K | 78.22% |
| 2025-06-30 | $409.27K | 19.93% |
| 2025-03-31 | $341.26K | -41.32% |
| 2024-12-31 | $581.58K | 4.81% |
| 2024-09-30 | $554.91K | 150.54% |
| 2024-06-30 | $221.48K | -18.31% |
| 2024-03-31 | $271.14K | 27.23% |
| 2023-12-31 | $213.11K | -12.79% |
| 2023-09-30 | $244.36K | -23.76% |
| 2023-06-30 | $320.51K | 9.02% |
| 2023-03-31 | $293.98K | 25.50% |
| 2022-12-31 | $234.24K | -32.58% |
| 2022-09-30 | $347.46K | 14.63% |
| 2022-06-30 | $303.11K | -5.69% |
| 2022-03-31 | $321.40K | 26.37% |
| 2021-12-31 | $254.33K | -5.66% |
| 2021-09-30 | $269.58K | -17.31% |
| 2021-06-30 | $326.01K | -1.14% |
| 2021-03-31 | $329.77K | 17.37% |
| 2020-12-31 | $280.96K | -10.29% |
| 2020-09-30 | $313.21K | 70.93% |
| 2020-06-30 | $183.23K | -29.66% |
| 2020-03-31 | $260.51K | - |
Femasys generated $729.39K in revenue during Q3 2025, up 78.22% compared to the previous quarter, and up 329.32% compared to the same period a year ago.
Femasys Revenue Breakdown
Femasys Revenue Breakdown by Country
Quarterly Revenue by Country
| Country | Sep 25 | Jun 25 |
|---|---|---|
| Non-US | $392.80K | $71.96K |
| UNITED STATES | $336.59K | $337.31K |
Latest
Femasys's latest quarterly revenue breakdown by geography, as of Sep 25: Non-US (53.85%), and UNITED STATES (46.15%).
Femasys Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| HBIO | Harvard Bioscience | $94.14M | $20.59M |
| EKSO | Ekso Bionics | $17.93M | $4.23M |
| VVOS | Vivos Therapeutics | $15.03M | $6.78M |
| CRIS | Curis | $10.91M | $2.75M |
| DARE | Daré Bioscience | $9.78M | $-21.17K |
| FEMY | Femasys | $1.63M | $729.39K |
| COCH | Envoy Medical | $316.00K | $42.00K |
| APLM | Apollomics | - | - |
| BCTX | BriaCell Therapeutics | - | - |
| AIMD | Ainos | - | $4.66K |
| PCSA | Processa Pharmaceuticals | - | - |